Inventor · disambiguated record
Livia Casciola-Rosen
Also filed as: CASCIOLA-ROSEN LIVIA · CASCIOLA-ROSEN LIVIA A · CASCIOLA-ROSEN LIVIA ANGELA
8 granted patents·9 pending applications·18 citations·filing 1999–2024
79Inventor score
Top patents by PatentIndex Score
17 records- 0174US2024342277A1Autoimmune antibodies for use in inhibiting cancer cell growthUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 0270US6855515B1Autoantigenic fragments, methods and assaysMERCK & CO INC·Filed 1999·Granted Feb 15, 2005·16 cites·5 claims
- 0367US8778618B2Compositions and methods for characterizing a myopathyCASCIOLA-ROSEN LIVIA ANGELA·Filed 2011·Granted Jul 15, 2014·2 cites·20 claims
- 0466US11938183B2Autoimmune antibodies for use in inhibiting cancer cell growthUNIV JOHNS HOPKINS·Filed 2021·Granted Mar 26, 2024·0 cites·17 claims
- 0565US2023104322A1Methods for identifying patterns of ifn induced expression and use in diagnosis, monitoring and therapyUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 0664US10874726B2Autoimmune antigens and cancerUNIV JOHNS HOPKINS·Filed 2014·Granted Dec 29, 2020·0 cites·15 claims
- 0759US11454630B2Materials and methods for assessing cancer risk and treating cancerUNIV JOHNS HOPKINS·Filed 2018·Granted Sep 27, 2022·0 cites·4 claims
- 0859US11366113B2Methods for identifying patterns of IFN induced expression and use in diagnosis, monitoring and therapyUNIV JOHNS HOPKINS·Filed 2018·Granted Jun 21, 2022·0 cites·9 claims
- 0958US9506924B2Compositions and methods for characterizing a myopathyUNIV JOHNS HOPKINS·Filed 2016·Granted Nov 29, 2016·0 cites·18 claims
- 1058US9335326B2Compositions and methods for characterizing a myopathyUNIV JOHNS HOPKINS·Filed 2014·Granted May 10, 2016·0 cites·21 claims
- 1156US2021100882A1Autoimmune antigens and cancerUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 1256US2024302367A1Methods and materials for treating cancerUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 1353US2024069023A1DETECTION OF ACE2 IgM AUTOANTIBODIES AS MARKERS OF SEVERITY AND MECHANISM IN COVID19 PATIENTSUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 1452US2024241118A1Autoantibodies for use in identifying diseaseUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 1551US2005112137A1Autoantigenic fragments, methods and assaysFiled 2004·Application pending·0 cites
- 1650US2015168398A1Methods for identifying patterns of ifn induced expression and use in diagnosis, monitoring and therapyUNIV JOHNS HOPKINS·Filed 2013·Application pending·0 cites
- 1746US2018104331A1Autoimmune antibodies for use in inhibiting cancer cell growthUNIV JOHNS HOPKINS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Livia Casciola-Rosen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →